Low Nevirapine Plasma Concentrations Predict Virological Failure in an Unselected HIV-1-Infected Population
- 1 January 2003
- journal article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 42 (6), 599-605
- https://doi.org/10.2165/00003088-200342060-00009
Abstract
To assess the relationship between plasma nevirapine concentrations and plasma HIV-1 RNA response in HIV-1-infected patients.Keywords
This publication has 21 references indexed in Scilit:
- Treatment Failure of Nelfinavir-Containing Triple Therapy Can Largely Be Explained by Low Nelfinavir Plasma ConcentrationsTherapeutic Drug Monitoring, 2003
- [Treatment adherence amongst HIV-infected patients in Rotterdam: poorer prognosis independent of nationality in heterosexual infected patients, intravenous drug users, Negroid and Latin-American patients].2002
- Limited Sampling Strategies for the Estimation of the Systemic Exposure to the HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor NevirapineTherapeutic Drug Monitoring, 2001
- Limited Patient Adherence to Highly Active Antiretroviral Therapy for HIV-1 Infection in an Observational Cohort StudyArchives of Internal Medicine, 2001
- Antiretroviral Treatment Simplification With Nevirapine in Protease Inhibitor–Experienced Patients With HIV-Associated LipodystrophyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Antiretroviral Treatment Simplification With Nevirapine in Protease Inhibitor–Experienced Patients With HIV-Associated LipodystrophyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- The Effect of Nevirapine in Combination With Nelfinavir in Heavily Pretreated HIV-1–Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- The Effect of Nevirapine in Combination With Nelfinavir in Heavily Pretreated HIV-1–Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- High‐Dose Nevirapine in Previously Untreated Human Immunodeficiency Virus Type 1‐Infected Persons Does Not Result in Sustained Suppression of Viral ReplicationThe Journal of Infectious Diseases, 1997
- Drug Evaluations Anti-infectives: Nevirapine: A review of its development, pharmacological profile and potential for clinical useExpert Opinion on Investigational Drugs, 1996